Bank of America’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-31,063
| Closed | -$556K | – | 7561 |
|
|
2017
Q4 | $556K | Sell |
31,063
-78,986
| -72% | -$972K | ﹤0.01% | 4880 |
|
|
2017
Q3 | $1.3M | Sell |
110,049
-2,548
| -2% | -$28.6K | ﹤0.01% | 4325 |
|
|
2017
Q2 | $1.18M | Buy |
112,597
+22,613
| +25% | +$231K | ﹤0.01% | 4315 |
|
|
2017
Q1 | $989K | Buy |
89,984
+16,730
| +23% | +$194K | ﹤0.01% | 4437 |
|
|
2016
Q4 | $993K | Buy |
73,254
+16,425
| +29% | +$229K | ﹤0.01% | 4344 |
|
|
2016
Q3 | $699K | Sell |
56,829
-33,299
| -37% | -$392K | ﹤0.01% | 4394 |
|
|
2016
Q2 | $989K | Buy |
90,128
+86,103
| +2,139% | +$964K | ﹤0.01% | 4191 |
|
|
2016
Q1 | $44K | Sell |
4,025
-11,928
| -75% | -$151K | ﹤0.01% | 5837 |
|
|
2015
Q4 | $276K | Buy |
15,953
+9,962
| +166% | +$179K | ﹤0.01% | 5173 |
|
|
2015
Q3 | $119K | Buy |
5,991
+2,427
| +68% | +$55.6K | ﹤0.01% | 5600 |
|
|
2015
Q2 | $59K | Buy |
3,564
+3,514
| +7,028% | +$60.9K | ﹤0.01% | 5867 |
|
|
2015
Q1 | $1K | Sell |
50
-3,950
| -99% | -$61.2K | ﹤0.01% | 6932 |
|
|
2014
Q4 | $57K | Buy |
4,000
+3,923
| +5,095% | +$41.4K | ﹤0.01% | 6270 |
|
|
2014
Q3 | $1K | Sell |
77
-4,823
| -98% | -$32K | ﹤0.01% | 7925 |
|
|
2014
Q2 | $34K | Sell |
4,900
-9,731
| -67% | -$68.8K | ﹤0.01% | 6908 |
|
|
2014
Q1 | $105K | Buy |
14,631
+6,923
| +90% | +$59.3K | ﹤0.01% | 5967 |
|
|
2013
Q4 | $72K | Sell |
7,708
-2,252
| -23% | -$16.1K | ﹤0.01% | 6352 |
|
|
2013
Q3 | $62K | Buy |
9,960
+3,856
| +63% | +$24.1K | ﹤0.01% | 6287 |
|
|
2013
Q2 | $40K | Buy |
+6,104
| New | +$48.4K | ﹤0.01% | 6684 |
|
Other funds holding SCMP
Bank of America's SCMP Position: Q1 2018 in Review
Bank of America sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 31,063 shares — an estimated $556K sold.
Bank of America first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $1.3M in Q3 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- Bank of America reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- Bank of America sold 31,063 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $556K.
- Bank of America first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- Bank of America's Sucampo Pharmaceuticals, Inc. position peaked at $1.3M in Q3 2017.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on Bank of America's 13F filing for Q1 2018, filed 15 May 2018.